Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker Corporation SYK recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker is acquiring Inari Medical for $80 per share in cash, representing a total equity value of approximately $4.9 billion, indicating a strong financial commitment to expand its portfolio.

The medical device maker plans to buy all of Inari’s common stock for $80 a share, representing a total fully diluted equity value of about $4.9 billion.

Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and (NASDAQ: NARI) for $80.00 ...

Danielle Antalffy; Analyst; UBS Equities Michael Polark; Analyst; Wolfe Research ...

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...